Missing/wrong data?
Log in to edit
A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer
scientific article
Author/s
author: Missak Haigentz, James Spicer, D Ross Camidge, Robert C Doebele, Eamon M Berge
Work details
Publication date
October 1, 2014
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.